The landscape of dementia diagnosis has progressed radically with the arrival of subtle biomarkers, like amyloid PET scans, tau imaging, and blood-centered tests that could detect Alzheimer's pathology decades prior to signs or symptoms arise. Whilst these technological improvements characterize outstanding progress in comprehension neurodegenerati